Jeppe Brandstrup

Jeppe Brandstrup currently serves as the Director of Business Development and M&A at LEO Pharma, beginning in September 2024. Prior to this role, Jeppe held the position of Vice President of Business Development at CellaVision from August 2016 to September 2024, contributing to a global leader in digital hematology. Jeppe's earlier experience includes roles as Senior Manager and Manager in M&A at Novozymes, as well as Senior Analyst and Analyst in M&A and Financial Analysis at DSB. Jeppe began the professional career as an Analyst in Corporate Finance at Ernst & Young. Educational qualifications include a Master’s Degree in Finance from Aarhus University and electives in Mergers & Acquisitions and Business Analysis from Harvard University, along with a Bachelor’s Degree in Economics & Business Administration from Aarhus University.